Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycemia in Diabetic Elders Trial
NCT02029846Phase 4Terminated
- Sponsor
- Johns Hopkins University
- Start
- Apr 2013
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Johns Hopkins University. Primary endpoint: Time to Achieve Glycemic Target (HbA1c <7.5%) at 6 months. Started Apr 2013; status: terminated.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02029846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02029846.